Non-steroidal Anti-inflammatory Drugs Market

Market Overview:

The global non-steroidal anti-inflammatory drugs market size is projected to exhibit a growth rate (CAGR) of 4.69% during 2024-2032. The emerging trend of self-medication and the growing consumer awareness regarding the benefits of over-the-counter (OTC) NSAIDs for pain relief represent some of the key factors driving the market.

Non-steroidal anti-inflammatory drugs (NSAIDs) are a type of medication that is used to reduce pain, fever, and inflammation. They work by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation in the body. Some common examples of NSAIDs include aspirin, ibuprofen, naproxen, diclofenac, etc. They are typically used to treat various conditions, including headaches, menstrual cramps, dental pain, muscle pain and inflammation, osteoarthritis, rheumatoid arthritis, etc. NSAIDs are available both over the counter and by prescription and can be taken orally, applied topically as a cream or gel, or injected into a joint or muscle.

The escalating demand for NSAIDs as an adjunct treatment for managing inflammation and pain associated with chronic conditions is primarily driving the global non-steroidal anti-inflammatory drugs market. In addition to this, the expanding geriatric population and the increasing utilization of pain relief medications to manage age-related conditions, such as arthritis and osteoporosis, are also bolstering the market growth. Moreover, the emerging popularity of topical NSAIDs, including gels and creams, since they are easier to apply and have a lower risk of side effects compared to oral NSAIDs, is further creating a positive outlook for the market. Apart from this, the rising trend of self-medication and the growing consumer awareness regarding the benefits of over-the-counter (OTC) NSAIDs for pain relief are also augmenting the market growth. Additionally, the escalating preference for NSAIDs over opioids for the treatment of pain, as they are safer and less likely to cause respiratory depression, is further acting as another significant growth-inducing factor. Besides this, ongoing advancements in drug delivery technology, such as the introduction of transdermal patches and targeted drug delivery systems, are making it easier to deliver NSAIDs directly to affected areas, potentially increasing their effectiveness, and reducing side effects. This, in turn, is expected to drive the global non-steroidal anti-inflammatory drugs market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global non-steroidal anti-inflammatory drugs market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on route of administration, disease indication, and distribution channel.

Route of Administration Insights:

• Oral
• Parenteral
• Topical
   

The report has provided a detailed breakup and analysis of the non-steroidal anti-inflammatory drugs market based on the route of administration. This includes oral, parenteral, and topical. According to the report, oral route of administration represented the largest segment.

Disease Indication Insights:

• Arthritis
• Migraine
• Ophthalmic Diseases
• Others
   

A detailed breakup and analysis of the non-steroidal anti-inflammatory drugs market based on the disease indication has also been provided in the report. This includes arthritis, migraine, ophthalmic diseases and others. According to the report, arthritis represented the largest segment.

Distribution Channel Insights:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
   

A detailed breakup and analysis of the non-steroidal anti-inflammatory drugs market based on the distribution channel has also been provided in the report. This includes hospital pharmacy, retail pharmacy and online pharmacy. According to the report, hospital pharmacy accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for non-steroidal anti-inflammatory drugs. Some of the factors driving the North America non-steroidal anti-inflammatory drugs market included rapid advancement of research and development activites and increasing healthcare expenditure.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global non-steroidal anti-inflammatory drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have also been provided. Some of the companies covered include Assertio Therapeutics, Inc., AstraZenca, Bayer AG, Dr. Reddy's Laboratories Limited, Eli Lilly and Company, GSK Plc, Horizon Therapeutics Public Limited Company, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Ltd, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Key Questions Answered in This Report:

• How has the global non-steroidal anti-inflammatory drugs market performed so far and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global non-steroidal anti-inflammatory drugs market?
• What is the impact of each driver, restraint, and opportunity on the global non-steroidal anti-inflammatory drugs market?
• What are the key regional markets?
• Which countries represent the most attractive non-steroidal anti-inflammatory drugs market?
• What is the breakup of the market based on the route of administration?
• Which is the most attractive route of administration of non-steroidal anti-inflammatory drugs market?
• What is the breakup of the market based on the disease indication?
• Which is the most attractive disease indication of non-steroidal anti-inflammatory drugs market?
• What is the breakup of the market based on distribution channel?
• Which is the most attractive distribution channel of non-steroidal anti-inflammatory drugs market?
• What is the competitive structure of the global non-steroidal anti-inflammatory drugs market?
• Who are the key players/companies in the global non-steroidal anti-inflammatory drugs market?

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the non-steroidal anti-inflammatory drugs market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global non-steroidal anti-inflammatory drugs market.
• The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the non-steroidal anti-inflammatory drugs industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.